American Renal Associates Holdings Inc (ARA) Return on Equity ROE from the third quarter 2020 to third quarter 2019 and annually, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
American Renal Associates Holdings Inc   (NYSE: ARA)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

American Renal Associates Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for American Renal Associates Holdings Inc in the third quarter 2020?
American Renal Associates Holdings Inc achieved a return on average equity (ROE) of 90.29 % in its third quarter 2020, which is below American Renal Associates Holdings Inc 's average return on equity, which stands at 1037.57%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Healthcare Facilities industry 2 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2020 from 154 to 226.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change -24.9 % 188.6 % - - -
Net Income (TTM) in Millions 34 39 29 26 5
Return On Equity (TTM) 90.29 % 2945.78 % 11085.93 % - -
ARA's Total Ranking # 226 # 154 # 257 # 397 # 1965
Equity (TTM) in Millions 71 -77 74 85 -76
Seq. Equity Change - - -12.76 % - -
Seq. Net Income Change -13.8 % - - -46.42 % 231.26 %

Back to ARA Management Effectiveness >> ARA's 5 Years Annual ROE >> Compare ARA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 3
Sector # 14
Overall # 226

Return On Equity Statistics
High Average Low
11085.93 %
1037.57 %
-3860.71 %
(Mar 31 2020)   (Jun 30 2018)





ARA Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2014)
2016
Total Equity in Millions 85 110 120 -123 0
Y / Y Equity Change -23.08 % -8.78 % - - -
Net Income in Millions 26 22 76 82 0
Y / Y Net Income Change 16.37 % -70.31 % -8.16 % - -
Return On Equity 30.93 % 20.44 % 62.82 % - -

Back to ARA Management Effectiveness >> ARA's 5 Years Annual ROE >> Compare ARA ROE to its Competitors




Annual Roe Comment
In 2019 ROE improved to 30.93 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ARA's' Return on Equity at Yahoo Finance
ARA's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ARA's Competitors
Subscribers only: Roe for American Renal Associates Holdings Inc 's Suppliers
Subscribers only: Return On Equity for ARA's Customers




Companies with similar Return On Equity at Sep 30 2020, within Healthcare Sector ROE
Abbvie Inc   204.66 %
Idexx Laboratories Inc  199.01 %
Xbiotech Inc   151.11 %
Eli Lilly And Company  146.99 %
Mettler toledo International Inc   142.98 %
Molecular Templates Inc   112.94 %
Co diagnostics Inc   102.14 %
Alpha Pro Tech Ltd   99.09 %
Integrated Biopharma Inc  94.28 %
American Renal Associates Holdings Inc   90.29 %
Coherus Oncology inc   88.44 %
Nrc Health  87.53 %
Sunlink Health Systems Inc   78.93 %
Amgen Inc   72.12 %
Vaso Corporation  70.24 %
Align Technology inc   68.99 %
Semler Scientific inc   67.37 %
Tenet Healthcare Corp  66.06 %
Catalyst Pharmaceuticals Inc   62.82 %
Innoviva Inc   62.32 %
Quidelortho Corp  56.48 %
Zoetis Inc   55.15 %
Biomx Inc  54.83 %
Retractable Technologies Inc  52.84 %
Zomedica Corp   51.31 %
Bio rad Laboratories Inc   49.89 %
Davita Inc   49.80 %
Hologic Inc  47.91 %
Viemed Healthcare Inc   46.98 %
3m Company  46.31 %

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.